| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
51,320,000 |
| Market
Cap: |
4.36(B) |
| Last
Volume: |
660,191 |
Avg
Vol: |
495,679 |
| 52
Week Range: |
$71.24 - $97.37 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P SMALLCAP 600 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 438 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
31,812 |
31,812 |
52,026 |
112,537 |
| Total Sell Value |
$2,869,033 |
$2,869,033 |
$4,659,768 |
$9,356,099 |
| Total People Sold |
4 |
4 |
5 |
9 |
| Total Sell Transactions |
11 |
11 |
16 |
32 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Galvin Roy |
President, Global Plasma & BC |
• • – |
2024-05-15 |
4 |
D |
$96.49 |
$20,649 |
D/D |
(214) |
4,538 |
|
- |
|
| Llorens Josep |
EVP, Global Manufacturing |
• • – |
2024-05-15 |
4 |
D |
$96.49 |
$24,894 |
D/D |
(258) |
18,205 |
|
- |
|
| Darecca James |
EVP, Chief Financial Officer |
• • – |
2024-05-15 |
4 |
D |
$96.49 |
$39,754 |
D/D |
(412) |
13,258 |
|
- |
|
| Maunsell Farris Maryanne |
VP, Chief Accounting Officer |
• • – |
2024-05-15 |
4 |
D |
$96.49 |
$7,044 |
D/D |
(73) |
557 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2024-05-15 |
4 |
D |
$96.49 |
$142,805 |
D/D |
(1,480) |
256,355 |
|
- |
|
| Lingamneni Anila |
EVP, Chief Technology Officer |
• • – |
2024-05-15 |
4 |
D |
$96.49 |
$32,517 |
D/D |
(337) |
11,958 |
|
- |
|
| Lingamneni Anila |
EVP, Chief Technology Officer |
• • – |
2024-05-06 |
4 |
AS |
$95.00 |
$218,975 |
D/D |
(2,305) |
12,295 |
|
-12% |
|
| Darecca James |
EVP, Chief Financial Officer |
• • – |
2024-05-02 |
4 |
D |
$93.33 |
$40,319 |
D/D |
(432) |
13,670 |
|
- |
|
| Lingamneni Anila |
EVP, Chief Technology Officer |
• • – |
2024-04-15 |
4 |
D |
$84.88 |
$15,618 |
D/D |
(184) |
14,311 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2024-03-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
38,900 |
257,546 |
|
- |
|
| Strong Stewart W |
President, Global Hospital |
• • – |
2023-10-20 |
4 |
D |
$89.05 |
$10,686 |
D/D |
(120) |
16,101 |
|
- |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2023-10-20 |
4 |
D |
$89.05 |
$17,543 |
D/D |
(197) |
32,272 |
|
- |
|
| Miller Laurie A. |
SVP, Human Resources |
• • – |
2023-09-15 |
4 |
D |
$90.11 |
$18,833 |
D/D |
(209) |
14,363 |
|
- |
|
| Strong Stewart W |
President, Global Hospital |
• • – |
2023-09-12 |
4 |
AS |
$90.65 |
$20,668 |
D/D |
(228) |
16,221 |
|
-6% |
|
| Lingamneni Anila |
EVP, Chief Technology Officer |
• • – |
2023-09-11 |
4 |
AS |
$90.00 |
$207,450 |
D/D |
(2,305) |
14,495 |
|
-7% |
|
| Dockendorff Charles J |
Director |
• • – |
2023-09-05 |
4 |
AS |
$87.68 |
$895,651 |
D/D |
(10,215) |
2,226 |
|
-5% |
|
| Pomeroy Claire |
Director |
• • – |
2023-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,226 |
11,972 |
|
- |
|
| Johnson Lloyd Emerson |
Director |
• • – |
2023-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,226 |
8,033 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2023-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,226 |
12,441 |
|
- |
|
| Abernathy Robert E |
Director |
• • – |
2023-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,226 |
20,081 |
|
- |
|
| Zane Ellen M |
Director |
• • – |
2023-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,226 |
14,473 |
|
- |
|
| Kroll Mark W |
Director |
• • – |
2023-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,226 |
18,457 |
|
- |
|
| Coyle Michael J |
Director |
• • – |
2023-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,226 |
10,494 |
|
- |
|
| Bryant Diane M |
Director |
• • – |
2023-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,226 |
2,226 |
|
- |
|
| Llorens Josep |
EVP, Global Manufacturing |
• • – |
2023-07-18 |
4 |
AS |
$90.00 |
$443,520 |
D/D |
(4,928) |
18,463 |
|
-11% |
|
1368 Records found
|
|
Page 3 of 55 |
|
|
0.92 (1.09%) 
